Product information

Current status:

Approved

Current status date:

1999-03-19

Product name:

LAMISIL DERMGEL

DIN:

02239876 Electronic product monograph is not available

Company:

NOVARTIS PHARMACEUTICALS CANADA INC
100 700 Rue Saint-Hubert
Montreal
Quebec
Canada H2Y 0C1

Class:

Human

Dosage form(s):

Gel

Route(s) of administration:

Topical

Number of active ingredient(s):

1

Schedule(s):

Prescription

American Hospital Formulary Service (AHFS): ^{See footnote 3}

84:04.08.04 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

D01AE15 TERBINAFINE

Active ingredient group (AIG) number:^{See footnote5}

0132855003